QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bier, D. M. Search for Related Content PubMed PubMed Citation Articles by Bier, D. M.

---

Supplement: 2nd Amino Acid Workshop

Amino Acid Pharmacokinetics and Safety Assessment¹

Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX 77030

² To whom correspondence should be addressed. E-mail: dbier{at}bcm.tmc.edu.

Tracer kinetic studies of amino acid metabolism during periods of high amino acid intake should allow insights into adaptive or maladaptive regulatory mechanisms controlling amino acid catabolic or disposal events before clinically evident effects. The principles of amino acid tracer kinetics have been well defined, but their application to establishing upper safe intake levels has been essentially nonexistent. Similarly, the pharmacology field has well-established disciplines of toxicokinetics (the relationship of toxicant dose and delivery to its site of action) and toxicodynamics (the relationship of toxicant at its site of action and downstream functional consequences), but these principles have not been transferred to the field of amino acid metabolism. In this context, a theoretical framework is presented for tracer kinetic experiments to help establish upper tolerable levels of amino acid infusion and/or ingestion. In addition, experiments to couple specific amino acid intake levels with their consequent physiological dynamic effects are suggested to lead to the construction of benefit-risk curves that may permit definition of safe amino acid intake ranges for the population.

KEY WORDS: • pharmacodynamics • toxicokinetics • toxicodynamics • physiologically based pharmacokinetic modeling • precursor-product relationships

This article has been cited by other articles:

				L. Cynober Introduction to the 5th Amino Acid Assessment Workshop. J. Nutr., June 1, 2006; 136(6 Suppl): 1633S - 1635S. [Abstract] [Full Text] [PDF]

				S. Toue, R. Kodama, M. Amao, Y. Kawamata, T. Kimura, and R. Sakai Screening of Toxicity Biomarkers for Methionine Excess in Rats J. Nutr., June 1, 2006; 136(6): 1716S - 1721S. [Abstract] [Full Text] [PDF]

				R. Sakai, M. Miura, M. Amao, R. Kodama, S. Toue, Y. Noguchi, and T. Kimura Potential Approaches to the Assessment of Amino Acid Adequacy in Rats: A Progress Report J. Nutr., June 1, 2004; 134(6): 1651S - 1655S. [Abstract] [Full Text] [PDF]

				K. Dabrowski, K.-J. Lee, and J. Rinchard The Smallest Vertebrate, Teleost Fish, Can Utilize Synthetic Dipeptide-Based Diets J. Nutr., December 1, 2003; 133(12): 4225 - 4229. [Abstract] [Full Text] [PDF]